Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

ClinicalTrials.gov ID: NCT02453334

Public ClinicalTrials.gov record NCT02453334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

IRON CLAD: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Multi-center, Randomized, Double-blinded, Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose Injection) in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase III, multicenter, randomized, double-blinded, prospective study with two parallel treatment groups. Patients who present to the hematologist/oncologist and satisfy all inclusion and exclusion criteria will be eligible for participation in this 18-week study.

Study identification

NCT ID
NCT02453334
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
American Regent, Inc.
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2015
Primary completion
Dec 31, 2017
Completion
Jan 3, 2018
Last update posted
May 10, 2021

2015 – 2018

United States locations

U.S. sites
29
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Compassionate Care Research Group, Inc. Corona California 92879
Compassionate Care Research Group, Inc. Fountain Valley California 92708
Compassionate Care Research Group, Inc. Riverside California 92501
University Cancer Institute Boynton Beach Florida 33426
AR Development Solutions Miami Lakes Florida 33014
Lakes Research Miami Lakes Florida 33014
H. Lee Moffitt Cancer Center Tampa Florida 33606
Bond Bond Clinic, P.A. Winter Haven Florida 33880
Joliet Oncology Hematology Associates Joliet Illinois 60435
MId-Illinois Hematology & Oncology Associates, Ltd. Normal Illinois 61761
OSF Saint Anthony Medical Center for Cancer Care Rockford Illinois 61108
Horizon Oncology Research, Inc. Lafayette Indiana 47905
Michiana Hematology Oncology, PC South Bend Indiana 46628
Northern Indiana Cancer Research Consortium South Bend Indiana 46628
Ashland-Bellefonte Cancer Center Ashland Kentucky 41101
Rcca Md, Llc Bethesda Maryland 20817
Antietam Oncology and Hematology Group, P.C. Hagerstown Maryland 21740
North Mississippi and Oncology Associates Tupelo Mississippi 38801
The Brookdale University Hospital and Medical Center Brooklyn New York 11212
Richmond University Medical Center Staten Island New York 10310
Montefiore Medical Center The Bronx New York 10467
East Chester Cancer Center The Bronx New York 10469
Waverly Hematology Oncology Cary North Carolina 27518
Kinston Medical Specialists Kinston North Carolina 28501
Gettysburg Cancer Center Gettysburg Pennsylvania 17325
Charleston Hematology/Oncology Associates, P.A. Charleston South Carolina 29414
Carolina Blood and Cancer Care, PA Rock Hill South Carolina 29732
Westchase Clinical Associates Houston Texas 77042
Bon Secours St. Francis Medical Center Midlothian Virginia 23114

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02453334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2021 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02453334 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →